| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.4M | -10.3% |
| Cost of Revenue | $3.3M | -26.5% |
| Gross Profit | $6.1M | +1.7% |
| R&D Expense | $5.2M | -58.0% |
| SG&A Expense | $25.2M | -1.9% |
| Operating Income | -$38.8M | -15.1% |
| Interest Expense | $2.9M | +14.4% |
| Net Income | -$37.4M | -8.6% |
| EPS (Basic) | -$0.39 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.4M | +159.2% |
| Accounts Receivable | $1.0M | -25.9% |
| Current Assets | $4.1M | +27.1% |
| Total Assets | $24.5M | -28.9% |
| Current Liabilities | $16.5M | -7.8% |
| Total Liabilities | $19.3M | -8.4% |
| Stockholders' Equity | $5.2M | -61.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.4M | +25.0% |
| Capital Expenditures | $24K | -7.7% |
| Investing Cash Flow | -$4.7M | -109.8% |
| Financing Cash Flow | $25.6M | -5.9% |
| Free Cash Flow | -$19.4M | +24.9% |
| +29.1% |